𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sodium Iodide Symporter and the Radioiodine Treatment of Thyroid Carcinoma

✍ Scribed by June-Key Chung; Hye Won Youn; Joo Hyun Kang; Ho Young Lee; Keon Wook Kang


Book ID
107686970
Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
271 KB
Volume
44
Category
Article
ISSN
1869-3474

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Radioiodine therapy of carcinoma of the
✍ Dr. Robert McConnell πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 212 KB

## Abstract The discovery of functioning metastases of thyroid carcinoma and their appropriate treatment with radioiodine are the keys to long‐term survival. Functioning metastases can be adequately found only if postsurgical residual normal thyroid tissue is ablated and total body scanning perform

Endogenous expression of the sodium iodi
✍ Florian C. Gaertner; Franziska Rohde; Jan Mueller; Birgit Blechert; Klaus-Peter πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 304 KB πŸ‘ 1 views

## Abstract The sodium iodide symporter (NIS) mediates iodide uptake into the thyroid. Because of this mechanism, differentiated thyroid cancer is susceptible for radioiodine therapy. Functional NIS expression in extrathyroidal tumors has been reported mainly in breast cancer. We screened colorecta

Genetically targeted radiotherapy of hea
✍ Andrew W. Gaut; Gang Niu; Kimberly J. Krager; Michael M. Graham; Douglas K. Tras πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 579 KB

## Abstract ## Background. Gene therapy that uses delivery of the sodium‐iodide symporter (NIS) gene followed by radioiodide administration has been proposed as a novel form of radiotherapy for nonthyroidal cancers. ## Methods. In vitro [^125^I] iodide accumulation and efflux from cells was dete